NeoGenomics, Inc.
NEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $417 | $406 | $230 | $819 |
| - Cash | $367 | $342 | $263 | $317 |
| + Debt | $605 | $612 | $611 | $613 |
| Enterprise Value | $656 | $675 | $577 | $1,115 |
| Revenue | $661 | $592 | $510 | $484 |
| % Growth | 11.6% | 16.1% | 5.2% | – |
| Gross Profit | $290 | $245 | $188 | $187 |
| % Margin | 43.9% | 41.3% | 36.9% | 38.6% |
| EBITDA | -$2 | -$18 | -$82 | -$65 |
| % Margin | -0.2% | -3% | -16.2% | -13.5% |
| Net Income | -$79 | -$88 | -$144 | -$8 |
| % Margin | -11.9% | -14.9% | -28.3% | -1.7% |
| EPS Diluted | -3.1 | -3.5 | -5.8 | -0.35 |
| % Growth | 11.4% | 39.7% | -1,557.1% | – |
| Operating Cash Flow | $7 | -$2 | -$66 | -$27 |
| Capital Expenditures | -$41 | -$29 | -$31 | -$64 |
| Free Cash Flow | -$34 | -$31 | -$97 | -$91 |